Ciprofloxacin vs Durvalumab

Ciprofloxacin vs Durvalumab: Overview

This comparison examines the pharmacological differences between Ciprofloxacin and Durvalumab.

Mechanism of Action

Ciprofloxacin: Inhibits bacterial DNA gyrase and topoisomerase IV.

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pharmacokinetics

Half-life: Ciprofloxacin — 4 hours; Durvalumab — 17 days.

Chemical Properties

Molecular Formula: Ciprofloxacin — C17H18FN3O3.

Molecular Weight: Ciprofloxacin — 331.3460 g/mol.

Type: Ciprofloxacin — Small molecule; Durvalumab — Antibody.